Eisai secures Japanese Aricept patent extension for severe Alzheimer's
This article was originally published in Scrip
Executive Summary
The Japanese patent relating to the use of Eisai's Aricept (donepezil) for the severe form of Alzheimer's disease has been extended to 22 June 2013, handing the company a victory in a long-running legal battle with potential generic competitors in this setting.